 | • レポートコード：20QY06-00866 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インスリンAPIのグローバル市場について種類別（通常型ヒトインスリン、インスリンアナログ）、用途別（速効型、プレミックス型、長時間型）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インスリンAPI市場の概要 ・世界の主要地域別インスリンAPI市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインスリンAPI市場規模2015-2026：種類別（通常型ヒトインスリン、インスリンアナログ） ・世界のインスリンAPI市場規模2015-2026：用途別（速効型、プレミックス型、長時間型） ・インスリンAPIの北米市場規模2015-2020 ・インスリンAPIのヨーロッパ市場規模2015-2020 ・インスリンAPIの中国市場規模2015-2020 ・インスリンAPIの日本市場規模2015-2020 ・インスリンAPIの東南アジア市場規模2015-2020 ・インスリンAPIのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、United Laboratory、Biocon、Torrent Pharma、Amphastar、Ganlee、Julphar Diabetes、Wockhardt） ・インスリンAPIの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インスリンAPIの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Insulin API Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Insulin API market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin API market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin API industry.
Based on our recent survey, we have several different scenarios about the Insulin API YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1812.1 million in 2019. The market size of Insulin API will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Insulin API market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Insulin API market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Insulin API market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Insulin API market. The report also includes nautical information, where it shows Insulin API market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Insulin API market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Insulin API market.
Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API
Geographical Analysis:
Based on region, the global Insulin API market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Insulin API market are
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
Torrent Pharma
Amphastar
Ganlee
Julphar Diabetes
Wockhardt
Segment by Type
Regular Human Insulin
Insulin Analogue
Segment by Application
Fast-acting
Premix
Long-acting
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Insulin API market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Insulin API market.
• The market share of the global Insulin API market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Insulin API market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Insulin API market.
1 Insulin API Market Overview
1.1 Insulin API Product Scope
1.2 Insulin API Segment by Type
1.2.1 Global Insulin API Sales by Type (2020-2026)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Insulin API Segment by Application
1.3.1 Global Insulin API Sales Comparison by Application (2020-2026)
1.3.2 Fast-acting
1.3.3 Premix
1.3.4 Long-acting
1.4 Insulin API Market Estimates and Forecasts (2015-2026)
1.4.1 Global Insulin API Sales Growth Rate (2015-2026)
1.4.2 Global Insulin API Revenue and Growth Rate (2015-2026)
1.4.3 Global Insulin API Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Insulin API Industry Impact
1.5.1 How the Covid-19 is Affecting the Insulin API Industry
1.5.1.1 Insulin API Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Insulin API Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Insulin API Players to Combat Covid-19 Impact
2 Insulin API Estimate and Forecast by Region
2.1 Global Insulin API Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Insulin API Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Insulin API Sales Market Share by Region (2015-2020)
2.2.2 Global Insulin API Revenue Market Share by Region (2015-2020)
2.3 Global Insulin API Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Insulin API Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Insulin API Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Insulin API Estimates and Projections (2015-2026)
2.4.2 Europe Insulin API Estimates and Projections (2015-2026)
2.4.3 China Insulin API Estimates and Projections (2015-2026)
2.4.4 Japan Insulin API Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Insulin API Estimates and Projections (2015-2026)
2.4.6 India Insulin API Estimates and Projections (2015-2026)
3 Global Insulin API Competition Landscape by Players
3.1 Global Top Insulin API Players by Sales (2015-2020)
3.2 Global Top Insulin API Players by Revenue (2015-2020)
3.3 Global Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2019)
3.4 Global Insulin API Average Price by Company (2015-2020)
3.5 Manufacturers Insulin API Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Insulin API Players (Opinion Leaders)
4 Global Insulin API Market Size by Type
4.1 Global Insulin API Historic Market Review by Type (2015-2020)
4.1.1 Global Insulin API Sales Market Share by Type (2015-2020)
4.1.2 Global Insulin API Revenue Market Share by Type (2015-2020)
4.1.3 Global Insulin API Price by Type (2014-2020)
4.2 Global Insulin API Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Insulin API Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin API Revenue Forecast by Type (2021-2026)
4.2.3 Global Insulin API Price Forecast by Type (2021-2026)
5 Global Insulin API Market Size by Application
5.1 Global Insulin API Historic Market Review by Application (2015-2020)
5.1.1 Global Insulin API Sales Market Share by Application (2015-2020)
5.1.2 Global Insulin API Revenue Market Share by Application (2015-2020)
5.1.3 Global Insulin API Price by Application (2015-2020)
5.2 Global Insulin API Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Insulin API Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin API Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin API Price Forecast by Application (2021-2026)
3 North America Insulin API Market Facts & Figures
3.2 North America Insulin API Sales Market Share by Company (2015-2020)
3.3 North America Insulin API Sales Market Share by Type (2015-2020)
3.4 North America Insulin API Sales Market Share by Application (2015-2020)
4 Europe Insulin API Market Facts & Figures
4.2 Europe Insulin API Sales Market Share by Company (2015-2020)
4.3 Europe Insulin API Sales Market Share by Type (2015-2020)
4.4 Europe Insulin API Sales Market Share by Application (2015-2020)
5 China Insulin API Market Facts & Figures
5.2 China Insulin API Sales Market Share by Company (2015-2020)
5.3 China Insulin API Sales Market Share by Type (2015-2020)
5.4 China Insulin API Sales Market Share by Application (2015-2020)
6 Japan Insulin API Market Facts & Figures
6.2 Japan Insulin API Sales Market Share by Company (2015-2020)
6.3 Japan Insulin API Sales Market Share by Type (2015-2020)
6.4 Japan Insulin API Sales Market Share by Application (2015-2020)
7 Southeast Asia Insulin API Market Facts & Figures
7.2 Southeast Asia Insulin API Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Insulin API Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Insulin API Sales Market Share by Application (2015-2020)
8 India Insulin API Market Facts & Figures
8.2 India Insulin API Sales Market Share by Company (2015-2020)
8.3 India Insulin API Sales Market Share by Type (2015-2020)
8.4 India Insulin API Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Insulin API Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Insulin API Corporation Information
12.1.2 Novo Nordisk Insulin API Business Overview and Total Revenue
12.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Insulin API Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi-Aventis
12.2.1 Sanofi-Aventis Insulin API Corporation Information
12.2.2 Sanofi-Aventis Insulin API Business Overview and Total Revenue
12.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi-Aventis Insulin API Products Offered
12.2.5 Sanofi-Aventis Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Insulin API Corporation Information
12.3.2 Eli Lilly Insulin API Business Overview and Total Revenue
12.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly Insulin API Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Tonghua Dongbao
12.4.1 Tonghua Dongbao Insulin API Corporation Information
12.4.2 Tonghua Dongbao Insulin API Business Overview and Total Revenue
12.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Tonghua Dongbao Insulin API Products Offered
12.4.5 Tonghua Dongbao Recent Development
12.5 United Laboratory
12.5.1 United Laboratory Insulin API Corporation Information
12.5.2 United Laboratory Insulin API Business Overview and Total Revenue
12.5.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.5.4 United Laboratory Insulin API Products Offered
12.5.5 United Laboratory Recent Development
12.6 Biocon
12.6.1 Biocon Insulin API Corporation Information
12.6.2 Biocon Insulin API Business Overview and Total Revenue
12.6.3 Biocon Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biocon Insulin API Products Offered
12.6.5 Biocon Recent Development
12.7 Torrent Pharma
12.7.1 Torrent Pharma Insulin API Corporation Information
12.7.2 Torrent Pharma Insulin API Business Overview and Total Revenue
12.7.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Torrent Pharma Insulin API Products Offered
12.7.5 Torrent Pharma Recent Development
12.8 Amphastar
12.8.1 Amphastar Insulin API Corporation Information
12.8.2 Amphastar Insulin API Business Overview and Total Revenue
12.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Amphastar Insulin API Products Offered
12.8.5 Amphastar Recent Development
12.9 Ganlee
12.9.1 Ganlee Insulin API Corporation Information
12.9.2 Ganlee Insulin API Business Overview and Total Revenue
12.9.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ganlee Insulin API Products Offered
12.9.5 Ganlee Recent Development
12.10 Julphar Diabetes
12.10.1 Julphar Diabetes Insulin API Corporation Information
12.10.2 Julphar Diabetes Insulin API Business Overview and Total Revenue
12.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Julphar Diabetes Insulin API Products Offered
12.10.5 Julphar Diabetes Recent Development
12.11 Wockhardt
12.11.1 Wockhardt Insulin API Corporation Information
12.11.2 Wockhardt Insulin API Business Overview and Total Revenue
12.11.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Wockhardt Insulin API Products Offered
12.11.5 Wockhardt Recent Development
13 Insulin API Manufacturing Cost Analysis
13.1 Insulin API Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insulin API
13.4 Insulin API Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insulin API Distributors List
14.3 Insulin API Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Insulin API Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Insulin API Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Insulin API Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Insulin API Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Insulin API Players to Combat Covid-19 Impact
Table 8. Global Market Insulin API Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Insulin API Sales (Kg) by Region (2015-2020)
Table 10. Global Insulin API Sales Market Share by Region (2015-2020)
Table 11. Global Insulin API Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Insulin API Revenue Share by Region (2015-2020)
Table 13. Global Insulin API Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Insulin API Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Insulin API Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Insulin API Revenue Share Forecast by Region (2021-2026)
Table 17. Global Insulin API (Kg) of Key Companies (2015-2020)
Table 18. Global Insulin API Sales Share by Company (2015-2020)
Table 19. Global Insulin API Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Insulin API Revenue Share by Company (2015-2020)
Table 21. Global Insulin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2019)
Table 22. Global Insulin API Average Price (K USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Insulin API Manufacturing Sites and Area Served
Table 24. Manufacturers Insulin API Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Insulin API Players
Table 27. Global Insulin API Sales (Kg) by Type (2015-2020)
Table 28. Global Insulin API Sales Share by Type (2015-2020)
Table 29. Global Insulin API Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Insulin API Price (Kg) by Type (2015-2020)
Table 31. Global Insulin API Sales Share by Type (2021-2026)
Table 32. Global Insulin API Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Insulin API Revenue Share by Type (2021-2026)
Table 34. Global Insulin API Price (Kg) by Type (2021-2026)
Table 35. Global Insulin API Sales (Kg) by Application (2015-2020)
Table 36. Global Insulin API Sales Share by Application (2015-2020)
Table 37. Global Insulin API Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Insulin API Price (Kg) by Application (2015-2020)
Table 39. Global Insulin API Sales (Kg) by Application (2021-2026)
Table 40. Global Insulin API Sales Share by Application (2021-2026)
Table 41. Global Insulin API Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Insulin API Revenue Share by Application (2021-2026)
Table 43. Global Insulin API Price (Kg) by Application (2021-2026)
Table 44. United States Insulin API Sales (Kg) by Company (2015-2020)
Table 45. United States Insulin API Sales Market Share by Company (2015-2020)
Table 46. United States Insulin API Sales (Kg) by Type (2015-2020)
Table 47. United States Insulin API Sales Market Share by Type (2015-2020)
Table 48. United States Insulin API Sales (Kg) by Application (2015-2020)
Table 49. United States Insulin API Sales Market Share by Application (2015-2020)
Table 50. Europe Insulin API Sales (Kg) by Company (2015-2020)
Table 51. Europe Insulin API Sales Market Share by Company (2015-2020)
Table 52. Europe Insulin API Sales (Kg) by Type (2015-2020)
Table 53. Europe Insulin API Sales Market Share by Type (2015-2020)
Table 54. Europe Insulin API Sales (Kg) by Application (2015-2020)
Table 55. Europe Insulin API Sales Market Share by Type (2015-2020)
Table 56. China Insulin API Sales (Kg) by Company (2015-2020)
Table 57. China Insulin API Sales Market Share by Company (2015-2020)
Table 58. China Insulin API Sales (Kg) by Type (2015-2020)
Table 59. China Insulin API Sales Market Share by Type (2015-2020)
Table 60. China Insulin API Sales (Kg) by Application (2015-2020)
Table 61. China Insulin API Sales Market Share by Application (2015-2020)
Table 62. Japan Insulin API Sales (Kg) by Company (2015-2020)
Table 63. Japan Insulin API Sales Market Share by Company (2015-2020)
Table 64. Japan Insulin API Sales (Kg) by Type (2015-2020)
Table 65. Japan Insulin API Sales Market Share by Type (2015-2020)
Table 66. Japan Insulin API Sales (Kg) by Application (2015-2020)
Table 67. Japan Insulin API Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Insulin API Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Insulin API Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Insulin API Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Insulin API Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Insulin API Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Insulin API Sales Market Share by Application (2015-2020)
Table 74. India Insulin API Sales (Kg) by Company (2015-2020)
Table 75. India Insulin API Sales Market Share by Company (2015-2020)
Table 76. India Insulin API Sales (Kg) by Type (2015-2020)
Table 77. India Insulin API Sales Market Share by Type (2015-2020)
Table 78. India Insulin API Sales (Kg) by Application (2015-2020)
Table 79. India Insulin API Sales Market Share by Application (2015-2020)
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 83. Novo Nordisk Insulin API Product
Table 84. Novo Nordisk Recent Development
Table 85. Sanofi-Aventis Corporation Information
Table 86. Sanofi-Aventis Description and Business Overview
Table 87. Sanofi-Aventis Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 88. Sanofi-Aventis Insulin API Product
Table 89. Sanofi-Aventis Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 93. Eli Lilly Insulin API Product
Table 94. Eli Lilly Recent Development
Table 95. Tonghua Dongbao Corporation Information
Table 96. Tonghua Dongbao Description and Business Overview
Table 97. Tonghua Dongbao Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 98. Tonghua Dongbao Insulin API Product
Table 99. Tonghua Dongbao Recent Development
Table 100. United Laboratory Corporation Information
Table 101. United Laboratory Description and Business Overview
Table 102. United Laboratory Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 103. United Laboratory Insulin API Product
Table 104. United Laboratory Recent Development
Table 105. Biocon Corporation Information
Table 106. Biocon Description and Business Overview
Table 107. Biocon Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 108. Biocon Insulin API Product
Table 109. Biocon Recent Development
Table 110. Torrent Pharma Corporation Information
Table 111. Torrent Pharma Description and Business Overview
Table 112. Torrent Pharma Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 113. Torrent Pharma Insulin API Product
Table 114. Torrent Pharma Recent Development
Table 115. Amphastar Corporation Information
Table 116. Amphastar Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 117. Amphastar Description and Business Overview
Table 118. Amphastar Insulin API Product
Table 119. Amphastar Recent Development
Table 120. Ganlee Corporation Information
Table 121. Ganlee Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 122. Ganlee Description and Business Overview
Table 123. Ganlee Insulin API Product
Table 124. Ganlee Recent Development
Table 125. Julphar Diabetes Corporation Information
Table 126. Julphar Diabetes Description and Business Overview
Table 127. Julphar Diabetes Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 128. Julphar Diabetes Insulin API Product
Table 129. Julphar Diabetes Recent Development
Table . Wockhardt Corporation Information
Table . Wockhardt Description and Business Overview
Table . Wockhardt Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2015-2020)
Table . Wockhardt Insulin API Product
Table . Wockhardt Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Insulin API Distributors List
Table 138. Insulin API Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin API Product Picture
Figure 2. Global Insulin API Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin API Market Share by Application in 2020 & 2026
Figure 6. Fast-acting Examples
Figure 7. Premix Examples
Figure 8. Long-acting Examples
Figure 9. Global Insulin API Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Insulin API Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Insulin API Price Trends Growth Rate (2015-2026) (K USD/Kg)
Figure 12. Global Insulin API Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Insulin API Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Insulin API Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Insulin API Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Insulin API Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Insulin API Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Insulin API Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Insulin API Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Insulin API Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Insulin API Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Insulin API Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Insulin API Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Insulin API Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Insulin API Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Insulin API Players Market Share by Revenue in Insulin API 2015 & 2019
Figure 27. Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Insulin API Revenue Share by Type (2015-2020)
Figure 29. Global Insulin API Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Insulin API Revenue Share by Application (2015-2020)
Figure 31. Global Insulin API Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Insulin API Sales Market Share by Type in 2019
Figure 33. United States Insulin API Sales Market Share by Type in 2019
Figure 34. Europe Insulin API Sales Market Share by Company in 2019
Figure 35. Europe Insulin API Sales Market Share by Type in 2019
Figure 36. Europe Insulin API Sales Market Share by Application in 2019
Figure 37. China Insulin API Sales Market Share by Company in 2019
Figure 38. China Insulin API Sales Market Share by Type in 2019
Figure 39. China Insulin API Sales Market Share by Application in 2019
Figure 40. Japan Insulin API Sales Market Share by Company in 2019
Figure 41. Japan Insulin API Sales Market Share by Type in 2019
Figure 42. Japan Insulin API Sales Market Share by Application in 2019
Figure 43. Southeast Asia Insulin API Sales Market Share by Company in 2019
Figure 44. Southeast Asia Insulin API Sales Market Share by Type in 2019
Figure 45. Southeast Asia Insulin API Sales Market Share by Application in 2019
Figure 46. India Insulin API Sales Market Share by Company in 2019
Figure 47. India Insulin API Sales Market Share by Type in 2019
Figure 48. India Insulin API Sales Market Share by Application in 2019
Figure 49. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Tonghua Dongbao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. United Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Torrent Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Amphastar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Julphar Diabetes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Insulin API
Figure 62. Manufacturing Process Analysis of Insulin API
Figure 63. Insulin API Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
インスリンリスプロの世界市場レポート2020 Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline i…- インスリンの世界市場レポート2020 A recently published report by QY Research titled Global Insulin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a …
- ヒト組み換えインスリンの世界市場レポート2020 A recently published report by QY Research titled Global Human Recombinant Insulin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides a…
- インスリン様成長因子の世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor Market The global Insulin Like Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin Like Growth Factor Scope and Market Siz…
- バイオシミラーインスリンの世界市場レポート2020 Market Analysis and Insights: Global Biosimilar Insulin Market The global Biosimilar Insulin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Biosimilar Insulin Scope and Market Size The global Biosimilar …